AbbVie's Humira sales may hold up better against biosimilars in the USA than they have in Europe. The pharmaceutical giant has a diverse portfolio of blockbuster drugs that should help to offset decli

5 Forever Dividend Stocks

07:00am, Tuesday, 14'th Mar 2023
These five dividend stocks make it a priority to return money to shareholders.
Diversification is a term widely used when it comes to investing in the stock market. It means spreading your investment across different sectors and industries to minimize volatility's impact.

DivHut Portfolio Update: February 2023

05:38am, Tuesday, 14'th Mar 2023
The system is clearly broken and has been for a while; however, I could find comfort in one thing, my dividends. These days, there are no shortages of accidental high yielding stocks but look at real
With the collapse of SVB Financial Group dominating the news and sending shockwaves again, we should look at recession-resilient companies like AbbVie. In fiscal 2022, AbbVie reported solid results, b

Final Trades: Oracle, Abbvie & Gold

02:31pm, Monday, 13'th Mar 2023
The "Halftime Report" traders give their top picks to watch for the second half.
The stock market is inherently volatile. With the economy going through the boom and bust cycles more frequently, the extreme ups and downs of the market are inevitable. For most conservative investor
AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
While most stocks pay quarterly dividends, investors can still construct a portfolio that allows them to get paid monthly if they position themselves carefully. Who doesn't like payday?
Medical Properties Trust is a real estate investment trust that offers a huge 11.5% dividend yield. Ally Financial is an all-digital bank that offers a 4.1% yield at the moment.

Is It Too Late to Buy AbbVie Stock?

05:30am, Thursday, 09'th Mar 2023
AbbVie expects U.S. sales of its blockbuster immunology drug Humira to decline 37% this year, as competition eats away at market share. But AbbVie's two newer immunology drugs could soon take over whe
AbbVie Inc. (NYSE:ABBV ) Cowen 43rd Annual Healthcare Conference Call March 7, 2023 9:10 AM ET Company Participants Roopal Thakkar - Senior Vice President, Development and Regulatory Affairs and Chief
Inflation and (expected) actions by the Federal Reserve continue to dominate market movements. Markets have started the new year with very solid gains following expectations about a more dovish Federa
Though the term dividend aristocrats generate plenty of interest for the underlying elite status, another even more rarefied category exists called dividend kings to buy. Rather than 25 years of conse

2 Top Dividend Kings to Buy for the Long Haul

09:53am, Saturday, 04'th Mar 2023
These aren't just dividend plays, either.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE